immunologisch middel	Interleukin 1 receptor antagonist	monoklonaal antilichaam
\|	\|	\|

canakinumab (substantie)
	canakinumab
	Canakinumab

Id	698091001
Status	Primitive

Has disposition

interleukine-1-receptorantagonist